Breeze Hunter thought she had a lingering cold. When her symptoms got worse, she was diagnosed with a rare form of cancer: ...

The ability of a mutation to cause cancer depends on how fast it forces cells to divide, according to a new study led by researchers at the Lunenfeld-Tanenbaum Research Institute (LTRI), Sinai Health ...

The ability of a mutation to cause cancer depends on how fast it forces cells to divide, according to a new study led by researchers at the ...

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...

Every day, doctors across various specialties diagnose cases of inflammatory arthritis, enteropathy, hyperinsulinemic ...

DelveInsight's "LUPKYNIS Market Size, Forecast, and Market Insight Report" highlights the details around LUPKYNIS, the first ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Cambridge: AstraZeneca has announced that Calquence (acalabrutinib) in combination with bendamustine and rituximab has been ...

AstraZeneca’s Calquence plus chemoimmunotherapy approved in EU to treat adult patients with previously untreated mantle cell lymphoma: Cambridge, UK Wednesday, May 7, 2025, 09:0 ...

Momentum is building for PROTAC treatments that eliminate disease-causing proteins, including those responsible for difficult ...

Enrollment is complete for the first groups of sickle cell patients taking pociredir and enrollment has begun for the 20 mg ...

Berikut adalah penjelasan lengkap terkait apa itu Klinefelter, mulai dari penyebab, tanda atau gejala, hingga cara mengobati.